Medical Discovery News, July 18, 2009
This week's radio broadcast focused on a vaccine, MCV4, that is effective against four of the most common bacteria that can cause meningitis. The Advisory Committee on Immunization Practices recommends use of MCV4 in persons aged 11 to 55, including routine vaccination of persons aged 11 to 18, ideally during the check-up at 11 to 12 years old. The vaccine is also recommended for college freshmen and for U.S. military recruits. Side effects from MCV4 are usually mild and serious side effects are rare. Medical Discovery News, hosted by UTMB's Norbert Herzog and David Niesel, is broadcast by nearly 100 stations in the U.S. and Mexico. Locally, you can hear the program at 10 a.m. on Saturdays on KUHT, 88.7 FM and KTSU, 90.9 FM.